Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer

Published:2018-04-27 Issue:5 Volume:67 Page:687-692
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Varughese Tilly¹,Taur Ying¹²,Cohen Nina³,Palomba M Lia²⁴,Seo Susan K¹²,Hohl Tobias M¹²,Redelman-Sidi Gil¹²

Affiliation:

1. Infectious Diseases Service, Memorial Sloan Kettering Cancer Center

2. Department of Medicine, Weill Cornell Medical College

3. Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York

4. Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York

Funder

National Cancer Institute

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/67/5/687/25496746/ciy175.pdf

Reference35 articles.

1. Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies;Advani;J Clin Oncol,2013

2. Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial;O’Brien;Lancet Oncol,2014

3. Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib;Byrd;Blood,2015

4. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia;Byrd;N Engl J Med,2013

5. Ibrutinib in previously treated Waldenström’s macroglobulinemia;Treon;N Engl J Med,2015

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer in People with HIV;Infectious Disease Clinics of North America;2024-09

2. Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments;Advances in Rheumatology;2024-08-21

3. Infections in patients with mantle cell lymphoma;HemaSphere;2024-07

4. Clinical Mycology Today: Emerging Challenges and Opportunities;Open Forum Infectious Diseases;2024-06-27

5. Cryptococcosis Associated With Biologic Therapy: A Narrative Review;Open Forum Infectious Diseases;2024-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3